Collectively, Class I HDACs are capable of modulating the Akt, MAPK and mTOR signalling pathways, as well as the expression of genes associated with hypertrophy, thereby contributing to the initiation and progression of cardiac hypertrophy. The gene discussed is MTOR; the disease is cardiac hypertrophy.